Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00334321 · ClinicalTrials.gov registry record · Phase 1

Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer Patients

A Phase 1 study of Endometrial Cancer, sponsored by Washington University School of Medicine.

Completed
Registry status
Phase 1
Development phase
65
Enrollment target
1
Study location

NCT00334321: Completed Phase 1 study of Endometrial Cancer, sponsored by Washington University School of Medicine.

NCT00334321 is a Phase 1 study of Endometrial Cancer that has completed, run by Washington University School of Medicine. The registered enrollment target is 65 participants, below the 524-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00334321, a Phase 1 study of Endometrial Cancer, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
Phase 1
Development phase
65 participants
Enrollment target
1
Study location

Study Summary

This study is evaluating the feasibility of using helical tomotherapy to deliver IMRT in post-hysterectomy endometrial cancer patients receiving adjuvant radiotherapy.

Primary Outcome

The study will be deemed infeasible if greater than 10% of patients experience one of the following: * Patient cannot be given the treatment because her anatomy is such that a dosimetrically satisfactory treatment plan cannot be devised for her. * The patient experiences any grade 4 acute toxicity judged to be related to her external radiation treatment. * Within 1 year of the start of radiation therapy, the patient develops any grade 4 late toxicity judged to be related to her external radiati

Conditions Studied

Interventions

  • DRUG Carboplatin
  • DRUG Paclitaxel
  • RADIATION IMRT
  • RADIATION Intracavitary vaginal brachytherapy

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2006-04
Est. Completion 2015-09
Phase Phase 1

What the finished NCT00334321 record still lists

NCT00334321 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 524-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (88% lower).

The record links to 1 condition, with Endometrial Cancer appearing as the primary indexed condition, and to 4 interventions - of which Carboplatin is the first listed.

NCT00334321 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT00334321 about?

NCT00334321 is a clinical study titled "Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer Patients". This study is evaluating the feasibility of using helical tomotherapy to deliver IMRT in post-hysterectomy endometrial cancer patients receiving adjuvant radiotherapy.

What is the current status of trial NCT00334321?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 65 participants. The study started on 2006-04. Estimated completion is 2015-09.

What conditions does trial NCT00334321 study?

This clinical trial studies the following conditions: Endometrial Cancer.

What interventions are being tested in trial NCT00334321?

The interventions under investigation include: Carboplatin (DRUG), Paclitaxel (DRUG), IMRT (RADIATION), Intracavitary vaginal brachytherapy (RADIATION).

Who is sponsoring clinical trial NCT00334321?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00334321 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Endometrial Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00334321's enrollment target sits among peer trials

65 112th of 181 higher than 70 of 181 other Endometrial Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Endometrial Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03366116 · 65 participants · Phase 1

    5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors

  • NCT03603730 · 65 participants · NA

    Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis

  • NCT03796559 · 65 participants · NA

    Magseed Enabled Long-Term Localization of Axillary Lymph Nodes

  • NCT03993106 · 65 participants · Phase 2

    A Study of sEphB4-HSA in Kaposi Sarcoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00334321, the US trial registry maintained by the National Library of Medicine. NCT00334321 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.